Table 5.
Blood Clotting Markers
Placebo | ACE | |||||||
---|---|---|---|---|---|---|---|---|
Test (Unit) | Reference ranges | Week 0 | Week 2 | P* | Week 0 | Week 2 | P* | P** |
aPTT (sec) | 22.7–35.8 | 25.35 ± 0.78 | 25.43 ± 0.83 | .896 | 25.30 ± 0.59 | 25.78 ± 0.63 | .441 | .429 |
Thrombin time (sec) | 17.2–23 | 17.87 ± 0.16 | 18.57 ± 0.27 | .026 | 17.76 ± 0.12 | 18.33 ± 0.24 | .040 | .695 |
Fibrinogen activity (mg/dL) | 170–410 | 311.17 ± 27.46 | 294.75 ± 22.53 | .127 | 330.75 ± 16.76 | 343.67 ± 24.02 | .364 | .257 |
The average ± standard deviation is shown.
P-values shown for the change from baseline to 2 weeks within each group.
P-values shown for the difference in the 2-week change between the two groups.
aPTT, activated partial thromboplastin time.